Akebia Therapeutics: HC Wainwright Raises PT to $6, Keeps Buy Rating

viernes, 6 de febrero de 2026, 7:33 am ET1 min de lectura
AKBA--

Akebia Therapeutics: HC Wainwright Raises PT to $6, Keeps Buy Rating

Akebia Therapeutics: HC Wainwright Raises PT to $6, Keeps Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios